Clinical trial
A Prospective, Randomized, Controlled Study on Self-monitoring of Blood Glucose (SMBG) Protocols in Predicting Glucose Levels in Senior Patients With Type 2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD)
NCT01954771 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled Study on Self-monitoring of Blood Glucose (SMBG) Protocols in Predicting Glucose Levels in Senior Patients With Type 2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD)
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- June 30, 2016
- Enrollment
- 89 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.